FDA Approved: OSPHENA — Supplemental Application (Duchesnay USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Osphena (ospemifene) from Duchesnay USA, Inc., likely updating its indications or labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspareunia Due to Menopause
• Vulvar and Vaginal Atrophy Due to Menopause

Drugs mentioned

• Osphena (ospemifene)

Snippet

SUPPL AP for OSPHENA (OSPEMIFENE)